Third Harmonic Bio, Inc.
THRD
$5.16
$0.030.59%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | -47.51% | -10.49% | 9.90% | 18.82% | 12.32% |
Total Depreciation and Amortization | 40.00% | 113.04% | 345.45% | 1,000.00% | 3,400.00% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 16.46% | -0.26% | 7.07% | 38.06% | 111.80% |
Change in Net Operating Assets | -500.45% | -109.11% | 46.63% | 93.22% | 104.90% |
Cash from Operations | -68.93% | -19.81% | 18.93% | 40.13% | 41.50% |
Capital Expenditure | 94.08% | 99.51% | 99.51% | -369.44% | -369.44% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | -- | -- |
Cash from Investing | 94.08% | 99.51% | 99.51% | -369.44% | -369.44% |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | 3,895.73% | 84,324.59% | -98.71% | -99.34% | -99.36% |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | 56.68% | 70.88% | 79.73% | 79.73% |
Cash from Financing | 6,221.15% | 5,946.00% | -98.93% | -99.57% | -99.59% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 180.79% | 188.21% | -113.74% | -111.92% | -112.29% |